Published by Josh White on 11th July 2024
(Sharecast News) - Faron Pharmaceuticals announced positive feedback from the FDA regarding the clinical development plan for its drug candidate bexmarilimab, aimed at treating myelodysplastic syndrome (MDS), on Thursday.
URL: http://www.digitallook.com/dl/news/story/34421198/...